A detailed history of Cetera Investment Advisers transactions in Nutri Band Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 18,900 shares of NTRB stock, worth $103,950. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,900
Holding current value
$103,950
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$5.98 - $10.72 $113,022 - $202,608
18,900 New
18,900 $133,000

Others Institutions Holding NTRB

About NutriBand Inc.


  • Ticker NTRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,803,260
  • Market Cap $42.9M
  • Description
  • Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid the...
More about NTRB
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.